1. Gill RK, Pant N, Saksena S, Singla A, Nazir TM, Vohwinkel L, Turner JR, Goldstein J, Alrefai WA, Dudeja PK. Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol, 2008; 294: G254-G262.
2. Blakely RD, Berson HE, Fremeau Jr RT, Caron MG, Peek MM, Prince HK, Bradley CC. Cloning and expression of a functional serotonin transporter from rat brain. Nature, 1991; 354: 66-70.
3. Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther, 1972; 181: 36-45.
4. Douglas JG, Munro JF. Drug treatment and obesity. Pharmac Ther, 1982; 18: 351-373.
5. Rowland NE, Carlton J. Neurobiology of an anorectic drug: Fenfluramine. Progress in Neurobiology, 1986; 7: 13-62.
6. Rudnick G, Wall SC. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl) tropane to the serotonin transporter. Mol Pharmacol, 1991; 40: 421-426.
7. Rudnick G, Wall SC. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol Pharmacol, 1993; 43: 271-276.
8. Den Boer JA, Westenberg HG. Effects of a serotonin and noradrenaline uptake inhibitor in panic disorder: a doublebind com-parative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol, 1988; 3: 59-74.
9. Den Boer JA, Westenberg HG. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology, 1990; 102: 85-94.
10. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD. Allelic Heterogeneity at the Serotonin Transporter Locus (SLC6A4) Confers Susceptibility to Autism and Rigid-Compulsive Behaviors. Am J Hum Genet, 2005; 77: 265-279.
11. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Molecular Psychiatry, 2003; 8: 933-936.
12. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F. Plasma serotonin levels and the platelet serotonin transporter. J Neurochem, 2007; 102: 206-215.
13. Ramamoorthy S, Cool DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD, Ganapathy V. Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem, 1993; 268: 21626-21631.
14. Lee SL, Fanburg BL. Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am J Physiol Cell Physiol, 1986; 250: C761-C765.
15. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology, 2004; 126:1657-1664.
16. Tate CG, Blakely RD. The effect of N-linked glycosylation on activity of the Na(+)- and Cl(−)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem, 1994; 269: 26303-26310.
17. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci, 2005; 25: 29-41.
18. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. p38 MAPK activation elevates serotonin transport activity via a traffickingindependent, protein phosphatase 2A-dependent process. J Biol Chem, 2005; 280: 15649-15658.
19. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinasedependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol, 2004; 65: 1462-1474.
20. El-Kasaby A, Just H, Malle E, Stolt-Bergner PC, Sitte HH, Freissmuth M, Kudlacek O. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J Biol Chem, 2010; 285: 39201-39210.
21. Larsen MB, Fjorback AW, Wiborg O. The C-terminus is critical for the functional expression of the human serotonin transporter. Biochemistry, 2006; 45: 1331-1337.
22. Nobukuni M, Mochizuki H, Okada S, Kameyama N, Tanaka A, Yamamoto H, Amano T, Seki T, Sakai N. The C-terminal region of serotonin transporter is important for its trafficking and glycosylation. J Pharmacol Sci, 2009; 111: 392-404.
23. Cobos EJ, Entrena JM, Nieto FR, Cendan CM, Del Pozo E. Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol, 2008; 6: 344-366.
24. Hayashi T, Su TP. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs, 2004; 18: 269-284.
25. Hayashi T, Maurice T, Su TP. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther, 2000; 293: 788-798.
26. Hayashi T, Su TP. The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol, 2005; 3: 267-280.
27. Hayashi T, Su TP. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci U S A, 2001; 98: 491-496.
28. Asano M, Motoike S, Yokota C, Usuki N, Yamamoto H, Urabe T, Katarao K, Hide I, Tanaka S, Kawamoto M, Irifune M, Sakai N. SKF-10047, a prototype Sigma-1 receptor agonist, augmented themembrane trafficking and uptake activity of the serotonin transporterand its C-terminus-deleted mutant via a Sigma-1receptor-independent mechanism. Journal of Pharmacological Sciences, 2019; 139: 29-36.
29. Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science, 1992; 257: 255-259.
30. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature, 1993; 362: 318-24.
31. Fasshauer D, Sutton RB, Brunger AT, Jahn R. Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc Natl Acad Sci U S A, 1998; 95: 15781-15786.
32. Teng FYH, Wang Y, Tang BL. The syntaxins. Genome Biology, 2001; 2(11): 3012.1–3012.7.
33. Bennett MK, García-Arrarás JE, Elferink LA, Peterson K, Fleming AM, Hazuka CD, Scheller RH. The syntaxin family of vesicular transport receptors. Cell, 1993; 74: 663-673.
34. Low SH, Chapin SJ, Weimbs T, Komuves LG, Bennett MK, Mostov KE. Differential localization of syntaxin isoforms in polarized Madin-Darby canine kidney cells. Mol Biol Cell, 1996; 7: 2007-2018.
35. Low SH, Chapin SJ, Wimmer C, Whiteheart SW, Kömüves LG, Mostov KE, Weimbs T. The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells. J Cell Biol, 1998; 141: 1503-1513.
36. Low SH, Vasanji A, Nanduri J, He M, Sharma N, Koo M, Drazba J, Weimbs T. Syntaxins 3 and 4 are concentrated in separate clusters on the plasma membrane before the establishment of cell polarity. Mol Biol Cell, 2006; 17: 977-989.
37. Delgrossi MH, Breuza L, Mirre C, Chavrier P, Le Bivic A. Human syntaxin 3 is localized apically in human intestinal cells. J Cell Sci, 1997; 110: 2207-2214.
38. Weimbs T, Low SH, Chapin SJ, Mostov KE. Apical targeting in polarized epithelial cells: There’s more afloat than rafts. Trends Cell Biol, 1997; 7: 393-399.
39. Li X, Low SH, Miura M, Weimbs T. SNARE expression and localization in renal epithelial cells suggest mechanism for variability of trafficking phenotypes. Am J Physiol Renal Physiol, 2002; 283: 1111-1122.
40. Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, Kitayama S, Dohi T, Mishima HK, Sakai N. Role of C-terminal region in the functional regulation of ratserotonin transporter (SERT). Neurochem Int, 2005; 46: 93-105.
41. Sakai N, Kodama N, Ohmori S, Sasaki K, Saito N. Involvement of the actin cytoskeleton in the regulation of serotonin transporter (SET) activity: possible mechanism underlying SET regulation by protein kinase C. Neurochem Int, 2000; 36: 567-579.
42. Katarao K, Murakawa S, Asano M, Usuki N, Yamamoto H, Shirafuji T, Tanaka S, Hide I, Sakai N. The development of screening methods to identify drugs to limit ER stress using wildtype and mutant serotonin transporter. Acta Histochem Cytochem, 2016; 49: 197-206.
43. Yamamoto H, Fujimiya M, Shirai Y, Nakashita M, Oyasu M, Saito N. Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neurosci Res, 1998; 32: 305-312.
44. Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeieton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci, 1992; 102: 581-600.
45. Bilan F, Nacfer M, Fresquet F, Norez C, Melin P, Martin-Berge A, Costa de Beauregard MA, Becq F, Kitzis A, Thoreau V. Endosomal SNARE proteins regulate CFTR activity and trafficking in epithelial cells. Exp Cell Res, 2008; 314: 2199-2211.
46. Wagner T, Dieckmann M, Jaeger S, Weggen S, Pietrzik CU. Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processing. Exp Cell Res, 2013; 319: 1956-1972.
47. Sabirzhanova I, Boinot C, Guggino WB, Cebotaru L. Syntaxin 8 and the Endoplasmic Reticulum Processing of ΔF508-CFTR. Cell Physiol Biochem, 2018; 51: 1489-1499.
48. 金本 聡自,今泉 和則.小胞体ストレスと疾患.ᝈ. Journal of Japanese Biochemical Society, 2018; 90: 51-59.
49. Suga K, Saito A, Akagawa K. ER stress response in NG108-15 cells involves upregulation of syntaxin 5 expression and reduced amyloid β peptide secretion. Exp Cell Res, 2015; 332: 11-23.
50. Gill RK, Pant N, Saksena S, Singla A, Nazir TM, Vohwinkel L, Turner JR, Goldstein J, Alrefai WA, Dudeja PK. Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol, 2008 ;294: G254-262.
51. Krause J. William. Krause's Essential Human Histology for Medical Students. Universal-Publishers, 2005 pp. 37-. ISBN 978-1-58112-468-2.
52. Gill RK, Shen L, Turner JR, Saksena S, Alrefai WA, Pant N, Esmaili A, Dwivedi A, Ramaswamy K, Dudeja PK. Serotonin modifies cytoskeleton and brush-border membrane architecture in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol, 2008; 295: G700-708.
53. Wiegerinck CL, Janecke AR, Schneeberger K, Vogel GF, van Haaften-Visser DY, Escher JC, Adam R, Thöni CE, Pfaller K, Jordan AJ, Weis CA, Nijman IJ, Monroe GR, van Hasselt PM, Cutz E, Klumperman J, Clevers H, Nieuwenhuis EE, Houwen RH, van Haaften G, Hess MW, Huber LA, Stapelbroek JM, Müller T, Middendorp S. Loss of Syntaxin 3 Causes Variant Microvillus Inclusion Disease. Gastroenterology, 2014; 147: 65-68.
54. Nazir S, Kumar A, Chatterjee I, Anbazhagan AN, Gujral T, Priyamvada S, Saksena S, Alrefai WA, Dudeja PK, Gill RK. Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways. PLoS One, 2015 May 8;10(5): e0120447.
55. ᳃森 寿,真鍋 俊世,渡辺雅彦,岡野 栄之,官川剛.脳神経科学イラストレイテッド 2000羊士社
56. Collaco A, Marathe J, Kohnke H, Kravstov D, Ameen N. Syntaxin 3 is necessary for cAMP- and cGMP-regulated exocytosis of CFTR: implications for enterotoxigenic diarrhea. Am J Physiol Cell Physiol, 2010; 299: C1450-C1460.
57. Darios F, Davletov, B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature, 2006; 440: 813-817.
58. Kennedy MJ, Davison IG, Robinson CG, Ehlers MD. Syntaxin-4 defines a domain for activity-dependent exocytosis in dendritic spines. Cell, 2010; 141: 524-35.
59. Mohanasundaram P, Shanmugam MM. Role of syntaxin 4 in activity-dependent exocytosis and synaptic plasticity in hippocampal neurons. Sci Signal, 2010; 3: jc7.
60. Jurado S, Goswami D, Zhang Y, Molina AJ, Südhof TC, Malenka RC. LTP requires a unique postsynaptic SNARE fusion machinery. Neuron, 2013; 77: 542-58.
61. Ciccone MA, Timmons M, Phillips A, Quick MW. Calcium/Calmodulin-Dependent Kinase II Regulates the Interaction between the Serotonin Transporter and Syntaxin 1A. Neuropharmacology, 2008; 55: 763-770.